| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3039731 | Clinical Neurology and Neurosurgery | 2015 | 7 Pages |
Abstract
The data showed that hdSD at rest and CBF-MCA after acetazolamide loading reflects ischemic symptoms of patients with moyamoya disease. Thus, these parameters could be used as ischemic symptom markers for following patients with moyamoya disease. hdSD at rest is important because it is less invasive and can be performed without acetazolamide loading.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Satoshi Takahashi, Yoshio Tanizaki, Hiroaki Kimura, Kazunori Akaji, Masaki Nakazawa, Kazunari Yoshida, Ban Mihara,